Observed Signal · Oct 30, 2026 · earnings · Source: SEC API · Impact: 4.2/5
10-Q Financial Filing Analysis for Kenvue (2026-10-30)
Kenvue Inc. reported its Q3 2026 financial results for the quarterly period ended September 27, 2026, delivering net sales of $3,886 million, up 3.2% year-over-year (2.9% organic growth driven by 1.6% volume and 1.3% price/mix). Operating income expanded 12.2% to $706 million as gross margin increased 40 basis points to 59.5%, supported by supply chain optimization, tariff refunds, and lower restructuring expenses ($33 million vs. $84 million in Q3 2025). Net income reached $430 million, up 8.0% from $398 million in the prior-year period, despite higher income tax expense. The quarter was framed by ongoing execution towards its pending merger with Kimberly-Clark Corporation (K-C), under which Kenvue shareholders will receive 0.14625 shares of K-C common stock plus $3.50 in cash per share (representing ~46% ownership of the combined entity). The HSR Act waiting period expired in February 2026, regulatory divestitures of feminine care assets are underway, and on September 28, 2026, K-C commenced exchange offers for up to $7.0 billion of Kenvue's Senior Notes.
This filing confirms resilient operational execution (positive organic growth and margin expansion across Self Care, Skin Health, and Essential Health) alongside key milestones toward closing the transformational Kimberly-Clark mega-merger, including debt exchange offers and required antitrust divestitures.
Track Kenvue Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Q3 2026 net sales reached $3,886 million with net income of $430 million ($0.22 per diluted share), while nine-month operating cash flows increased 39.8% year-over-year to $1,877 million.
- Pending acquisition by Kimberly-Clark Corporation remains on track: Kenvue shareholders will receive 0.14625 K-C shares plus $3.50 in cash per share; K-C launched exchange offers for up to $7.0 billion of Kenvue Senior Notes on September 28, 2026.
- The 2026 Restructuring Initiative incurred $41 million in Q3 charges ($188 million year-to-date toward an estimated $250 million total) and targets annualized gross savings of approximately $200 million.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
8-K Financial Filing Analysis for Kimberly-Clark (2026-11-02)
On November 2, 2026, Kimberly-Clark Corporation (K-C) completed its acquisition of Kenvue Inc. Under the merger terms, Kenvue shareholders received $3.50 in cash and 0.14625 shares of K-C common stock per share, requiring K-C to issue approximately 281,060,840 common shares. In connection with the transaction, K-C's Board approved the Kenvue Integration Program through December 31, 2029, expecting cumulative pre-tax restructuring and integration charges of approximately $3.1 billion ($2.5 billion in cash and $0.6 billion non-cash) alongside $1.4 billion in related capital expenditures to achieve targeted operational synergies by 2030. Governance and compensatory actions accompanying the close include the appointment of three former Kenvue directors—Richard E. Allison, Jr., Larry J. Merlo, and Kirk L. Perry—to K-C's Board, replacing three resigning directors. Furthermore, K-C granted premium-priced, nonqualified stock options to executive leadership, including $6.6 million in grant value to CEO Michael Hsu, with exercise prices set at a minimum of $120.00 or 110% of the grant-date stock price, vesting December 1, 2029.
8-K Financial Filing Analysis for Kenvue (2026-11-02)
On November 2, 2026, Kenvue Inc. completed its merger with Kimberly-Clark Corporation (K-C), becoming a direct, wholly owned subsidiary named Kenvue LLC. Under the terms of the merger agreement, each share of Kenvue common stock was converted into the right to receive 0.14625 shares of K-C common stock plus $3.50 in cash. In connection with the closing, Kenvue terminated its $4.0 billion revolving credit agreement with JPMorgan Chase Bank, N.A., under which no borrowings were outstanding. Kenvue's entire 12-member board of directors resigned, and common stock was requested to be delisted from the New York Stock Exchange. Additionally, Kenvue LLC entered into a Fourth Supplemental Indenture assuming all obligations under seven tranches of outstanding senior notes aggregating $7.0 billion.
10-Q Financial Filing Analysis for Kenvue (2026-08-06)
Kenvue reported its Q2 2026 financial results with net sales growing 3.0% year-over-year to $3.96 billion (1.6% organic growth), driven by pricing actions across international markets and strong e-commerce performance. Operating income reached $699 million and net income grew 8.6% to $456 million ($0.24 diluted EPS), supported by a lower effective tax rate of 23.7%. Operating cash flows for the first six months strengthened to $1.18 billion. Strategically, Kenvue is advancing toward the completion of its pending merger with Kimberly-Clark Corporation, expected to close in Q4 2026 following shareholder approvals and U.S. antitrust clearance. The company also initiated its 2026 Restructuring Initiative aimed at driving supply chain efficiencies and delivering $200 million in annualized pre-tax gross savings.
Receive all future signals for Kenvue & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.